Send to

Choose Destination
Food Chem Toxicol. 2012 May;50(5):1226-37. doi: 10.1016/j.fct.2012.01.040. Epub 2012 Feb 4.

Mechanism of cisplatin resistance in human urothelial carcinoma cells.

Author information

Graduate Institute of Life Sciences, National Defense Medical Center, 161Minquan E. Road, Section 6, Neihu Dist., Taipei City 114, Taiwan, ROC.,


An isogenic pair of cisplatin-susceptible (NTUB1) and -resistant (NTUB1/P) human urothelial carcinoma cell lines was used to elucidate the mechanism of cisplatin resistance. The significantly lower intracellular platinum (IP) concentration, which resulted from the decreased cisplatin uptake, was found in NTUB1/P cells. The enhancement of IP concentration did not increase the susceptibility of NTUB1/P cells to cisplatin treatment. The reduction of IP concentration as well was unable to enhance the cisplatin-resistance in susceptible NTUB1 cells. This indicated that reduction of IP concentration was not the account for the development of cisplatin resistance here. Instead, the over expression of anti-apoptotic Bcl-2, anti-oxidative heme oxygenase-1 (HO-1) and cell cycle regulator p16INK4 seemed to be more important for the gaining of cisplatin in these human urothelial carcinoma cell.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center